COVID-19 inactivated vaccine products are seen at a packaging plant of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, Dec. 25, 2020. (Xinhua/Zhang Yuwei)
BUDAPEST, Jan. 30 (Xinhua) -- Hungary authorized the use of China's Sinopharm COVID-19 vaccine, Hungarian Chief Medical Officer Cecilia Muller said on Friday.
"Today the National Institute of Pharmacy and Nutrition gave its approval for the Sinopharm vaccine," Muller told a briefing.
Besides the Pfizer-BioNTech and Moderna vaccines acquired through the European Union, Hungary has also approved Russia's Sputnik V and the British AstraZeneca COVID-19 vaccines.
As the world is struggling to contain the pandemic, vaccination is underway in some countries with the already-authorized coronavirus vaccines.
Meanwhile, 236 candidate vaccines are still being developed worldwide -- 63 of them in clinical trials -- in countries including Germany, China, Russia, Britain and the United States, according to information released by the World Health Organization on Tuesday. ■
